Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 28

Sort by

Sort Order Select

Journal Articles

Chronic Opioid Use Is Highly Prevalent in Patients Undergoing Allogeneic Transplant and Impacts Long Term Outcomes

Karen Sweiss, Kaily Kurzweil, Gregory S Calip, Lisa Sharp, Nadia Nabulsi, Mahir Khan, Damiano Rondelli, Pritesh R Patel

Blood (2021) 138 (Supplement 1): 1823.

https://doi.org/10.1182/blood-2021-154472

Published: 2021

Journal Articles

Racial and Age-Related Differences in Impacts of High-Risk Cytogenetic Abnormalities on Survival in Multiple Myeloma in a Nationwide Electronic Health Record-Derived Database

Gregory S Calip, Mustafa S Ascha, Xiaoliang Wang, Amy E Pierre, Kathleen Maignan, Niquelle B Wadé, Siyang Leng, Erlene K Seymour, Brian C-H Chiu, Karen Sweiss, Pritesh R Patel, Natalia Neparidze

Blood (2021) 138 (Supplement 1): 4121.

https://doi.org/10.1182/blood-2021-152774

Published: 2021

Journal Articles

Social and Demographic Factors Contributing to COVID-19 Vaccine Hesitancy in Patients with Hematologic Malignancies

Karen Sweiss, Meredith Russell, Gregory S Calip, Ryan Nguyen, Meshaal Khan, Eshana Shah, Ronald Ng, Kaily Kurzweil, Mahir Khan, Ammarah Nadeem, Lisa Wendt, Nicole Fuchs, Elaine Trinh, Damiano Rondelli, Pritesh R Patel

Blood (2021) 138 (Supplement 1): 841.

https://doi.org/10.1182/blood-2021-154339

Published: 2021

Journal Articles

The Cytotoxic Effect of the PARP Inhibitor ABT-888 on Myeloproliferative Neoplasms

Pritesh R. Patel, MB, ChB, Vitalyi Senyuk, PhD, Elisa Bonetti, PhD, Dolores Mahmud, PhD, Shrihari S. Kadkol, MD PhD, Annie L. Oh, MD, Nadim Mahmud, MD PhD, Damiano Rondelli, MD

Blood (2016) 128 (22): 4276.

https://doi.org/10.1182/blood.V128.22.4276.4276

Published: 2016

Journal Articles

Improved Survival in African American Patients Undergoing Autologous Transplant for Multiple Myeloma in the Chemotherapy and Novel Agent Era

Karen Sweiss, PharmD, Annie L. Oh, MD, Gregory S. Calip, PharmD, MPH, PhD, Damiano Rondelli, MD, Pritesh R. Patel, MD

Blood (2016) 128 (22): 4631.

https://doi.org/10.1182/blood.V128.22.4631.4631

Published: 2016

Journal Articles

Blood and Marrow Transplantation (BMT) in Acute Leukemia Patients in Cuba: Current Results and Future Opportunities through International Collaboration

Calixto Hernandez Cruz, Jose Carnot Uria, Jorge Munio Perurena, Wilfredo Torres Yribar, Jesus Diego de la Campa, Yusaima Rodriguez Fraga, Julio Antonio Lopez Silva, Isbel Moya Perez, Carmen Rosa Rodriguez Rodriguez, Kali Cepero Llauger, Ibis Karina Pardo Ramirez, Karen Sweiss, PharmD, Pritesh R. Patel, MD, Damiano Rondelli, MD

Blood (2016) 128 (22): 5959.

https://doi.org/10.1182/blood.V128.22.5959.5959

Published: 2016

Journal Articles

Cytopenia of Unknown Cause Post Allogeneic Stem Cell Transplant As a Predictor of Clinical Outcome

Annie L. Oh, MD, Krishna Ghimire, MD, Nandini Kalakota, MD, Karen Sweiss, PharmD, Pritesh R. Patel, MB, ChB, Damiano Rondelli, MD

Blood (2016) 128 (22): 5761.

https://doi.org/10.1182/blood.V128.22.5761.5761

Published: 2016

Journal Articles

Racial Differences in Long-Term Risk of Venous Thromboembolism Among Older Patients Following Diagnosis and Treatment of Multiple Myeloma

Sruthi Adimadhyam, MS, Karen Sweiss, PharmD, Pritesh R. Patel, MD, Brian C.-H. Chiu, PhD, Gregory S. Calip, PharmD, MPH, PhD

Blood (2016) 128 (22): 2071.

https://doi.org/10.1182/blood.V128.22.2071.2071

Published: 2016

Journal Articles

C75 Fatty Acid Synthesis (FAS) Inhibitor Has Potent Immunosuppressive Activity

Vitalyi Senyuk, PhD, Dolores Mahmud, PhD, Annie L. Oh, MD, Pritesh R. Patel, MD, Damiano Rondelli, MD

Blood (2016) 128 (22): 2156.

https://doi.org/10.1182/blood.V128.22.2156.2156

Published: 2016

Journal Articles

A Prospective Study of IV Pentamidine for Pneumocystis Jirovecii Pneumonia Prophylaxis in Adult Patients with Hematologic Malignancies Undergoing Hematopoietic Stem Cell Transplant or Chemotherapy

Jennifer Anderson, PharmD, Scott Wirth, PharmD, Pritesh R. Patel, MD, John G. Quigley, MD, Annie L. Oh, MD, Christina Mactal-Haaf, PharmD, Irum Khan, MD, Damiano Rondelli, MD, Karen Sweiss, PharmD

Blood (2016) 128 (22): 2207.

https://doi.org/10.1182/blood.V128.22.2207.2207

Published: 2016

Journal Articles

A Phase 1 Study of Total Marrow Irradiation Combined with High-Dose Melphalan for Patients with Relapsed/ Refractory Multiple Myeloma

Pritesh R. Patel, MB, ChB, Annie L. Oh, MD, Matthew Koshy, MD, Bulent Aydogan, PhD, Karen Sweiss, PharmD, John G. Quigley, MD, Santosh L. Saraf, MD, Irum Khan, MD, Eileen D. Hacker, PhD APN, AOCN, Nadim Mahmud, MD PhD, David J. Peace, MD, Howard Ozer, MD PhD, Jennifer Windhorst, APN, Ralph R Weichselbaum, MD, Damiano Rondelli, MD

Blood (2016) 128 (22): 4646.

https://doi.org/10.1182/blood.V128.22.4646.4646

Published: 2016

Journal Articles

In-Vitro and in-Vivo Synergistic Effect of Melphalan and Dual DNA Repair Inhibition in Multiple Myeloma

Pritesh R. Patel, MB, ChB, Annie L. Oh, MD, Vitalyi Senyuk, PhD, Dolores Mahmud, PhD, Nadim Mahmud, MD PhD, Damiano Rondelli, MD

Blood (2016) 128 (22): 3301.

https://doi.org/10.1182/blood.V128.22.3301.3301

Published: 2016

Journal Articles

Race and Socioeconomic Factors Influencing Treatment Disparities and Comparative Effectiveness in Very Elderly Patients with Diffuse Large B-Cell Lymphoma

Gregory S. Calip, PharmD, MPH, PhD, Sruthi Adimadhyam, MS, Pritesh R. Patel, MD, Karen Sweiss, PharmD, Ashley B. Cha, BA, Benjamin J. Nagy, BS, Kellyn M. Moran, PharmD, Sonali M. Smith, MD, Brian C.-H. Chiu, PhD

Blood (2016) 128 (22): 841.

https://doi.org/10.1182/blood.V128.22.841.841

Published: 2016

Journal Articles

Melphalan 200 Mg/m2 in Patients with Renal Impairment Is Associated with Increased Short Term Toxicity but Improved Response and Longer Treatment-Free Survival

Karen Sweiss, PharmD, Katie Culos, PharmD, Seema Patel, PharmD, Annie L. Oh, MD, Damiano Rondelli, MD, Pritesh R. Patel, MB, ChB

Blood (2015) 126 (23): 1998.

https://doi.org/10.1182/blood.V126.23.1998.1998

Published: 2015

Journal Articles

Dual DNA Damage Repair Inhibition Synergizes with Alkylator Chemotherapy for Myeloma and Acute Leukemia

Pritesh R. Patel, MB, ChB, Vitalyi Senyuk, PhD, Dolores Mahmud, PhD, Annie L. Oh, MD, Damiano Rondelli, MD

Blood (2015) 126 (23): 2053.

https://doi.org/10.1182/blood.V126.23.2053.2053

Published: 2015

Journal Articles

Preclinical Study for the Use of Abatacept to Prevent Rejection of Allogeneic CD34+ Cells in a Xenograft Model

Annie L. Oh, MD, Dolores Mahmud, PhD, Vitalyi Senyuk, PhD, Elisa Bonetti, PhD, Nadim Mahmud, MD PhD, Pritesh R. Patel, MB, ChB, Damiano Rondelli, MD

Blood (2015) 126 (23): 4271.

https://doi.org/10.1182/blood.V126.23.4271.4271

Published: 2015

Journal Articles

Alemtuzumab/Low Dose Radiation Conditioning Regimen in Allogeneic Hematopoietic Stem Cell Transplantation for Adult Patients with Sickle Cell Disease (SCD)

Santosh L. Saraf, MD, Annie L. Oh, MD, Dolores Mahmud, PhD, Pritesh R. Patel, MB, ChB, Karen Sweiss, PharmD, Matthew Koshy, MD, Sally Campbell-Lee, MD, Michel Gowhari, DO, Johara Hassan, MD, David Peace, MD, John G. Quigley, MD, Irum Khan, MBBS, Robert E. Molokie, MD, Lewis L. Hsu, MD PhD, Nadim Mahmud, MD PhD, Dennis J Levinson, MD, Victor R. Gordeuk, MD, Damiano Rondelli, MD

Blood (2014) 124 (21): 2703.

https://doi.org/10.1182/blood.V124.21.2703.2703

Published: 2014

Journal Articles

Synergistic Cytotoxic Effect Of The PARP Inhibitor ABT888 and Busulfan In Acute Leukemia Cell Lines

Pritesh R. Patel, MB, ChB, Dolores Mahmud, Ph.D., Damiano Rondelli, MD

Blood (2013) 122 (21): 4936.

https://doi.org/10.1182/blood.V122.21.4936.4936

Published: 2013

Journal Articles

Co-Stimulatory Blockade With CTLA4-Ig Permits Transplantation Of Human Hematopoietic Stem Cells and HLA Incompatible T Cells In NOD/SCID γ Null (NSG) Mouse Model

Annie L. Oh, MD, Dolores Mahmud, Ph.D., Benedetta Nicolini, Ph.D., Nadim Mahmud, MD, PhD, Elisa Bonetti, BS, Pritesh R. Patel, MB, ChB, Damiano Rondelli, MD

Blood (2013) 122 (21): 1999.

https://doi.org/10.1182/blood.V122.21.1999.1999

Published: 2013

Journal Articles

Genomic Signature Predicts Resistance To Busulfan In AML Cell Lines

Pritesh R. Patel, MB, ChB, Dolores Mahmud, Ph.D., Wei Zhang, PhD, Joe GN Garcia, MD, Damiano Rondelli, MD

Blood (2013) 122 (21): 3850.

https://doi.org/10.1182/blood.V122.21.3850.3850

Published: 2013

NARROW

Chronic Opioid Use Is Highly Prevalent in Patients Undergoing Allogeneic Transplant and Impacts Long Term Outcomes

Racial and Age-Related Differences in Impacts of High-Risk Cytogenetic Abnormalities on Survival in Multiple Myeloma in a Nationwide Electronic Health Record-Derived Database

Social and Demographic Factors Contributing to COVID-19 Vaccine Hesitancy in Patients with Hematologic Malignancies

The Cytotoxic Effect of the PARP Inhibitor ABT-888 on Myeloproliferative Neoplasms

Improved Survival in African American Patients Undergoing Autologous Transplant for Multiple Myeloma in the Chemotherapy and Novel Agent Era

Blood and Marrow Transplantation (BMT) in Acute Leukemia Patients in Cuba: Current Results and Future Opportunities through International Collaboration

Cytopenia of Unknown Cause Post Allogeneic Stem Cell Transplant As a Predictor of Clinical Outcome

Racial Differences in Long-Term Risk of Venous Thromboembolism Among Older Patients Following Diagnosis and Treatment of Multiple Myeloma

C75 Fatty Acid Synthesis (FAS) Inhibitor Has Potent Immunosuppressive Activity

A Prospective Study of IV Pentamidine for Pneumocystis Jirovecii Pneumonia Prophylaxis in Adult Patients with Hematologic Malignancies Undergoing Hematopoietic Stem Cell Transplant or Chemotherapy

A Phase 1 Study of Total Marrow Irradiation Combined with High-Dose Melphalan for Patients with Relapsed/ Refractory Multiple Myeloma

In-Vitro and in-Vivo Synergistic Effect of Melphalan and Dual DNA Repair Inhibition in Multiple Myeloma

Race and Socioeconomic Factors Influencing Treatment Disparities and Comparative Effectiveness in Very Elderly Patients with Diffuse Large B-Cell Lymphoma

Melphalan 200 Mg/m2 in Patients with Renal Impairment Is Associated with Increased Short Term Toxicity but Improved Response and Longer Treatment-Free Survival

Dual DNA Damage Repair Inhibition Synergizes with Alkylator Chemotherapy for Myeloma and Acute Leukemia

Preclinical Study for the Use of Abatacept to Prevent Rejection of Allogeneic CD34+ Cells in a Xenograft Model

Alemtuzumab/Low Dose Radiation Conditioning Regimen in Allogeneic Hematopoietic Stem Cell Transplantation for Adult Patients with Sickle Cell Disease (SCD)

Synergistic Cytotoxic Effect Of The PARP Inhibitor ABT888 and Busulfan In Acute Leukemia Cell Lines

Co-Stimulatory Blockade With CTLA4-Ig Permits Transplantation Of Human Hematopoietic Stem Cells and HLA Incompatible T Cells In NOD/SCID γ Null (NSG) Mouse Model

Genomic Signature Predicts Resistance To Busulfan In AML Cell Lines

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only